Hyaluronic Acid Nanoparticles for Immunogenic Chemotherapy of Leukemia and T-Cell Lymphoma

Ratiometric delivery of combination chemotherapy can achieve therapeutic efficacy based on synergistic interactions between drugs. It is critical to design such combinations with drugs that complement each other and reduce cancer growth through multiple mechanisms. Using hyaluronic acid (HA) as a ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Krishnan, Vinu, Dharamdasani, Vimisha, Bakre, Shirin, Dhole, Ved, Wu, Debra, Budnik, Bogdan, Mitragotri, Samir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874923/
https://www.ncbi.nlm.nih.gov/pubmed/35214193
http://dx.doi.org/10.3390/pharmaceutics14020466

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874923/
https://www.ncbi.nlm.nih.gov/pubmed/35214193
http://dx.doi.org/10.3390/pharmaceutics14020466

Ejemplares similares